Arcudi III Louis J 4
4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Arcudi III Louis J
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-12-07+74,400→ 74,400 totalExercise: $10.39Exp: 2028-12-06→ Common Stock (74,400 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on November 1, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.